Search Results - Wilgucki, Molly, DO

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Osimertinib and Capmatinib Combination Therapy to Overcome MET Y1003N-Mediated Resistance in EGFR-Mutant NSCLC: A Case Report

    Osimertinib and Capmatinib Combination Therapy to Overcome MET Y1003N-Mediated Resistance in EGFR-Mutant NSCLC: A Case Report by Wilgucki, Molly, DO, Yeung, Vincent, MD, Ho, Grace, MD, Bravo Montenegro, Gabriela L., MD, Jones, Greg, Reuss, Joshua E., MD, Liu, Stephen V., MD, Kim, Chul, MD, MPH

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Antibody–Drug Conjugates in Non-Small Cell Lung Cancer: Emergence of a Novel Therapeutic Class

    Antibody–Drug Conjugates in Non-Small Cell Lung Cancer: Emergence of a Novel Therapeutic Class by Marks, Jennifer A., Wilgucki, Molly, Liu, Stephen V., Reuss, Joshua E.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Overcoming the hurdles: surmounting acquired resistance to anti-EGFR therapy in metastatic colorectal cancer

    Overcoming the hurdles: surmounting acquired resistance to anti-EGFR therapy in metastatic colorectal cancer by Sackstein, Paul E, Chintapally, Nikita, Wilgucki, Molly, Hartley, Marion L, Alqahtani, Ali, Weinberg, Benjamin A

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Osimertinib and Capmatinib Combination Therapy to Overcome MET Y1003N-Mediated Resistance in EGFR-Mutant NSCLC: A Case Report

    Osimertinib and Capmatinib Combination Therapy to Overcome MET Y1003N-Mediated Resistance in EGFR-Mutant NSCLC: A Case Report by Wilgucki, Molly, Yeung, Vincent, Ho, Grace, Bravo Montenegro, Gabriela L, Jones, Greg, Reuss, Joshua E, Liu, Stephen V, Kim, Chul

    Get full text
    Report
    Save to List
    Saved in:

Search Tools: